Slide 1: EBOS Group Limited 94th Annual Meeting
For personal use only EBOS Group Limited 94th Annual Meeting 19 October 2016
Slide 2: Important Information
Important Information The information in this presentation was prepared by EBOS Group Ltd with due care and attention. However, the information is supplied in summary For personal use only form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness
Slide 3: 2016 Annual Meeting: Chairman – Mr Mark Waller
For personal use only 2016 Annual Meeting 1 Chairman – Mr Mark Waller 3
Slide 4: Agenda
Agenda • Welcome For personal use only • Introducing members of the Board • Presentations – Mark Waller, Chairman – Patrick Davies, Chief Executive Officer • Business of meeting • Conclusion 4
Slide 5: Board of Directors
Board of Directors For personal use only Mark Waller Independent Chairman of Directors Appointed 1987 Appointed Chairman 2015 Elizabeth Coutts Peter Kraus Stuart McGregor Sarah Ottrey Barry Wallace Peter Williams Independent Director Non-executive Director Non-executive Director Independent Director
Slide 6: Record Revenue and Profit Performance for FY16
Record Revenue and Profit Performance for FY16 Total Revenue Return on Capital Employed 7.1b 16.3% For personal use only $ Up 17.0% (+16.5% Constant FX) Up 260bps Total EBITDA Earnings per share $ 225.5m Up 14.6% (+14.0% Constant FX) 84.0c Up 18.7% (+18.2% Constant FX) Total NPAT Final Divid
Slide 7: Financial Trends
Financial Trends 5 Year Revenue Trend (NZ$m) 5 Year EBITDA Trend (NZ$m) For personal use only 2016 7,101 2016 225.5 2015 6,068 2015 196.7 2014 5,757 2014 175.4 2013 1,822 2013 57.0 2012 1,427 2012 45.1 Revenue Split – FY16 EBITDA Split – FY16 New New Zealand 21% Zealand 20% 79% Australia 80% Austral
Slide 8: Business Segment overview
Business Segment overview ANIMAL For personal use only CARE 16% Animal Care 16% Consumer Products 6% Contract Pharmacy Logistics 49% 9% (Wholesale and Retail) Institutional HEALTHCARE Healthcare 84% 20% Data based on Gross Operating Revenue FY16 8
Slide 9: 2016 Annual Meeting: CEO – Mr Patrick Davies
For personal use only 2016 Annual Meeting 2 CEO – Mr Patrick Davies A-Frame automatic picking system, Symbion Keysborough facility, 9 Melbourne, Australia
Slide 10: EBOS Approach
EBOS Approach Our Healthcare and Animal Care strategic focus is centred on For personal use only Disciplined Capital Investing for Growth Leading Market Positions Management Two types of investments: We aim to have positions of scale • Cash generation to drive scope for • External acquisitions – we
Slide 11: FY16 Highlights
FY16 Highlights For personal use only Investments of $108.4m made in FY16 • Acquisition of Red Seal (November 2015) • Acquisition of Zest (October 2015) • Onelink’s NSW Health contract commenced • Initial investment made in a new distribution centre in Brisbane, Queensland • BlackHawk like-for-like
Slide 12: Corporate video
Corporate video For personal use only • The corporate video that will be shown at the Annual Meeting can be viewed on the EBOS Group website at www.ebosgroup.com 12
Slide 13: FY16 Divisional Performance
FY16 Divisional Performance For personal use only Constant FX • Healthcare Revenue increased $993.5m or 16.9% due NZ$m FY16 FY15 Var Var to: Healthcare segment – new Hepatitis C drug sales in Australia of $465m, albeit at Revenue 6,686.4 5,692.9 17.5% 16.9% lower gross profit margins – Strong OTC pr
Slide 14: FY17 Trading Update
FY17 Trading Update For personal use only • We have made a positive start to the first quarter of FY17, notwithstanding the higher NZD:AUD exchange rate which has been evident. On the basis of our current trading performance we expect constant currency, underlying net profit after tax for the 2017 f
Slide 15: 2016 Annual Meeting: Business of the Meeting
For personal use only 2016 Annual Meeting 3 Business of the Meeting Selection of our branded products from Red Seal, Faulding, Vitapet and BlackHawk 15
Slide 16: Annual Report and Financial Statements
Item 1 Annual Report and Financial Statements For personal use only • To consider and receive the annual report and the financial statements for the year ended 30 June 2016 and the audit report thereon. 16
Slide 17: Director re-election – Elizabeth Coutts
Item 2 Director re-election – Elizabeth Coutts For personal use only To consider the re-election of Elizabeth Coutts as a Director of the Company. Elizabeth Coutts retires by rotation and being eligible, offers herself for re- election. Elizabeth Coutts ONZM, BMS, CA Independent Director Elizabeth C
Slide 18: Director re-election – Peter Williams
Item 3 Director re-election – Peter Williams For personal use only To consider the re-election of Peter Williams as a Director of the Company. Peter Williams retires by rotation and being eligible, offers himself for re- election. Peter Williams Non-executive Director Peter Williams was appointed to
Slide 19: Director re-election – Mark Waller
Item 4 Director re-election – Mark Waller For personal use only To consider the re-election of Mark Waller as a Director of the Company. Mark Waller retires by rotation and being eligible, offers himself for re- election. Mark Waller BCOM, FACA, FNZIM Independent Chairman of Directors Mark Waller wa
Slide 20: Auditor fees and expenses
Item 5 Auditor fees and expenses For personal use only • That the directors be authorised to fix the fees and expenses of Deloitte as the auditor of the Company. 20
Slide 21: Thank you for attending
For personal use only 2016 Annual Meeting Thank you for attending Please join us for refreshments www.ebosgroup.com